Hepatitis C virus (HCV) affects over 70 million people globally, with an estimated 399 000 HCV‐related deaths in 2016. The World Health Organization (WHO) has set a goal to eliminate HCV by 2030. Despite the availability of direct‐acting antivirals—highly effective and well‐tolerated therapies for HCV—many patients infected with HCV in Germany have not initiated treatment, including a majority of those who are aware of their positive diagnosis. Barriers to screening, diagnosis, and treatment are major factors taking many countries off track for HCV elimination by 2030. Identifying country‐specific barriers and challenges, particularly in at‐risk populations such as people who inject drugs or men who have sex with men, has the potential to create tailored programs and strategies to increase access to screening or treatment and engage at‐risk populations. This review aims to report the current steps toward HCV elimination in Germany, the country‐specific barriers and challenges that will potentially prevent reaching the 2030 HCV elimination goal and describe good practice examples to overcome these barriers.
SummaryWas im Urlaub reizvoll erscheint, kann in der Sprechstundeim günstigsten Fall zu Verständnisproblemen,aber auch zu Abwehr bis hin zu einer aggressiven Grundhaltungund ausbleibenden Behandlungserfolgen führen.Sprachliche und kulturelle Unterschiede, verschiedeneSichtweisen auf Gesundheit und Krankheit undpersönliche Erfahrungen mit den jeweiligen Gesundheitssystemennehmen Einfluss auf die Interaktion zwischenPatient und Therapeut.Die Autorin stellt die Ansätze der transkulturellen Kommunikationvor, die helfen kann, über Gemeinsamkeiteneine Brücke zwischen den Kulturen zu bauen.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.